SERTAD2 antisense RNA 1 (SERTAD2-AS1)

SERTAD2 antisense RNA 1 (SERTAD2-AS1) is a long non-coding RNA transcribed antisense to the SERTAD2 gene. Antisense RNAs are typically involved in the regulation of their sense (i.e., protein-coding) gene partner through mechanisms such as blocking mRNA translation, recruiting chromatin remodeling complexes, and influencing epigenetic marks. No direct drug targeting or disease-association information is available for SERTAD2-AS1 as of current knowledge. Antisense RNAs (asRNAs/lncRNAs) like SERTAD2-AS1 generally function as regulators of gene expression rather than as direct therapeutic targets, though there is scientific interest in manipulating such RNAs for therapy or as biomarkers. The SERTAD2 gene (its sense partner) encodes a protein with transcription coactivator activity and roles in cell growth and metabolism, but SERTAD2-AS1 is a distinct non-coding transcript. No data were found on drug interactions, safety, biomarkers, or specific disease associations for SERTAD2-AS1 in the returned search results. This lncRNA is a regulatory molecule, not an established therapeutic target.

Not defined for drugs as no drugs are known to interact with or target SERTAD2-AS1. Antisense lncRNAs generally function by blocking mRNA translation or recruiting chromatin-modifying complexes to regulate gene expression.